NCT06094790View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

November 15, 2017

Conditions
Healthy
Interventions
DRUG

CORT125134 150 mg

CORT125134 150 mg (3 X 50 mg current capsule formulation)

DRUG

CORT125134 250 mg

CORT125134 250 mg (5 X 50 mg current capsule formulation)

DRUG

CORT125134 dose to be determined

CORT125134 current capsule formulation, dose to be determined

Trial Locations (1)

33126

Quotient Sciences, Miami, Inc., Miami

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY